Dr. Thomas John Savides, MD

Dr. Savides practices at UCSD Hillcrest Medical Center in San Diego, California.

Dr. Savides' NPI, 1588649081, was assigned on December 7, 2005. Dr. Savides graduated from UC San Diego School of Medicine in 1987. Dr. Savides holds California license G064139.

Dr. Savides' primary practice is UCSD Hillcrest Medical Center, at 200 W Arbor Dr, San Diego, CA 92103 in San Diego County. The practice phone is (619) 543-6222.

Dr. Savides' primary practice is UCSD Hillcrest Medical Center in San Diego, California. Dr. Savides is also affiliated with Hillcrest Medical Center. The medical group on file is UC San Diego Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Savides practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Savides' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Savides is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Savides is licensed in California.

Dmand AI lists acid reflux, colonoscopy, gastroenteritis, gastrointestinal bleeding, hemorrhoids, intestinal diverticulosis, intestinal or bowel obstruction and irritable bowel syndrome (IBS) among the conditions Dr. Savides treats.

CMS data shows 858 Medicare services from Dr. Savides across 17 procedure codes in 2024, for 489 Medicare patients. Medicare paid $96,671 for them.

CMS counts 489 Medicare patients who saw Dr. Savides in 2024. The largest group is 75 to 84, with 229 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Savides' median patient age at 66, with 58% women.

In 2024, Dr. Savides wrote 421 Medicare Part D claims for 248 patients. 89% of them were for generic drugs. CMS names the drug for 358 of them, across 8 drugs with 11 or more claims each, at $85,215 in total drug cost. In 2023, CMS named 307 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Savides for performance year 2024, reported as part of a group. Dr. Savides accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Savides as offering telehealth. CMS counts 348 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Savides, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 109 papers to Dr. Savides, published from 2005 to 2025. 2018 was the busiest year, with 3. The most frequent topics are Endosonography, Pancreatic Neoplasms and Cholangiopancreatography, Endoscopic Retrograde. Dr. Savides has published most often in Gastrointest Endosc. Dr. Savides' most frequent co-authors are Syed M.a. Fehmi, MD, MS, Santiago Horgan and Garth R. Jacobsen, MD.

Dmand AI links Dr. Savides to 1 clinical trial. Conditions studied include Klatskin Tumor and Bile Duct Neoplasms. Open Payments lists research payments to Dr. Savides that name 1 trial.

CMS Open Payments shows 124 general payments to Dr. Savides from 15 drug and device companies from 2016 to 2025. Education make up the largest share, 50% of the total. Olympus Corporation of the Americas paid the most, $50,461. It also lists 2 research payments totaling $3,600 in 2016, naming 1 clinical trial.

Dmand AI lists 18 awards for Dr. Savides, most recently "Top Doctors" in Gastroenterology in 2015.

Dr. Savides graduated from UC San Diego School of Medicine in 1987. Dr. Savides is a member of AGA and ASGE.

Dr. Savides is in network with 15 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.